Malek Shatila, MD

University of Texas MD Anderson Cancer Center

Poster(s):

• P1603 - The Interplay Between Immunocompromise and Immunotherapy Affects the Risk of Inflammatory Adverse Events
  Monday, October 23, 2023

  10:30 AM – 4:15 PM PT

• P1604 - Practice Changes in Management of Gastrointestinal Immune-Related Adverse Events at a Tertiary Care Cancer Center
  Monday, October 23, 2023

  10:30 AM – 4:15 PM PT

• P2742 - Helicobacter pylori Seropositivity Is Associated With Worse Outcomes Among Patients on Immunotherapy for Gastric Cancer
  Monday, October 23, 2023

  10:30 AM – 4:15 PM PT